{
  "meta": {
    "title": "Imaging_Modalities_Surgeries_Endoscopy_Radiotherapy_And_Chemotherapy_In_Gyane",
    "url": "https://brainandscalpel.vercel.app/imaging-modalities-surgeries-endoscopy-radiotherapy-and-chemotherapy-in-gyane-730c291b.html",
    "scrapedAt": "2025-11-30T08:49:42.511Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Transabdominal ultrasound</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Hysterosalpingography (HSG)</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which imaging technique is considered the gold standard for evaluating the extent of fibroids and their relationship with the uterine cavity?</span></p>",
      "unique_key": "DT1289650",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289650,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207d3d680d2-e449-4a4e-984d-dffdadd1acdd.jpg\">\r\n<p><strong>OPTION A:</strong> While <strong>transabdominal ultrasound</strong> is commonly used as an initial imaging technique to detect uterine fibroids due to its accessibility and cost-effectiveness, it <strong>is not the gold standard for detailed evaluation</strong>. It can identify fibroids and assess their size, but it provides less detailed information about their relationship to the uterine cavity compared to MRI.</p>\r\n<p><strong>OPTION B:</strong> <strong>Hysterosalpingography (HSG) </strong>is primarily used to evaluate the patency of the fallopian tubes and assess the uterine cavity for structural abnormalities. It is not the gold standard for evaluating the extent or detailed characteristics of fibroids, as <strong>it mainly focuses on assessing the uterine cavity and tubal patency</strong> rather than providing comprehensive details about fibroid size and location.</p>\r\n<p><strong>OPTION C: MRI is considered the gold standard for evaluating fibroids</strong> because it provides <strong>superior soft tissue contrast</strong> and <strong>detailed images of the fibroids</strong>, including their size, number, and location. MRI is particularly useful for assessing the relationship of fibroids to the uterine cavity, which is critical for planning treatment and surgical interventions.</p>\r\n<p><strong>OPTION D: </strong>While CT scans can be useful for evaluating certain gynecological conditions, they are not typically used as the primary imaging technique for fibroids. <strong>CT scans are less effective than MRI in differentiating between types of soft tissue and may expose patients to additional radiation, making MRI the preferred method for detailed evaluation of fibroids.</strong></p>\r\n<p><strong>KEY TAKEAWAY: </strong>MRI is considered the gold standard for evaluating uterine fibroids due to its ability to provide detailed and accurate images of fibroids and their impact on the uterus and surrounding structures.</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Start hormonal therapy</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform a hysteroscopy</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat ultrasound in 6 months</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Order an MRI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman undergoing evaluation for abnormal uterine bleeding has an endometrial thickness of 12 mm on ultrasound. What is the next best step in management?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207ff0653c6-0485-4ffd-85bf-2540005c8b27.jpg\"></span></p>",
      "unique_key": "DT1289653",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289653,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Performing a hysteroscopy is the most appropriate next step because it allows direct visualization of the endometrial cavity.</strong> This procedure is useful for diagnosing endometrial pathology such as polyps, fibroids, or endometrial hyperplasia, which can be associated with increased endometrial thickness. It also allows for <strong>potential biopsy of abnormal tissue for histological examination</strong>, which is crucial for accurate diagnosis and treatment planning.</p>\r\n<p><strong>OPTION A: </strong>Hormonal therapy might be considered if there is a diagnosis of hormonal imbalance or if symptoms are related to hormonal issues. However, it does not address the need to evaluate the cause of the abnormal endometrial thickness. <strong>Without determining the underlying cause, starting hormonal therapy could be empirical and might not resolve the underlying issue.</strong></p>\r\n<p><strong>OPTION C: Repeating the ultrasound in 6 months might delay the diagnosis and management of potential endometrial pathology.</strong> While follow-up imaging might be necessary in some cases, the current abnormal endometrial thickness warrants further investigation rather than postponing evaluation.</p>\r\n<p><strong>OPTION D: </strong>While MRI provides detailed imaging and can be useful for assessing the extent and characteristics of endometrial pathology, it is not the first-line investigation for evaluating abnormal endometrial thickness. <strong>Hysteroscopy is preferred for direct evaluation and biopsy, which are essential for diagnosis. MRI may be considered later if additional detailed imaging is required.</strong></p>\r\n<p><strong>KEY TAKEAWAY: </strong></p>\r\n<p><strong>For premenopausal women, an endometrial thickness (ET) of 12 mm is generally considered above the normal range and warrants further evaluation.</strong> The specific cut-off values can vary based on guidelines and clinical practice, but typically:</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412078b7a5a7f-b049-4126-a46d-ef92af855c93.jpg\">\r\n<p>For <strong>postmenopausal women</strong>, an <strong>endometrial thickness (ET) of 4 mm</strong><strong> or greater generally prompts further evaluation</strong> due to the increased risk of endometrial pathology, including endometrial cancer.</p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine fibroids</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial carcinoma</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenomyosis</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic endometritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old multiparous woman is undergoing MRI for AUB. The MRI report notes a junctional zone (JZ) thickness of greater than 12 mm (as shown in the image). Based on this finding, what is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207395a9c91-57ec-49eb-b00a-a01d75ee6cee.jpg\"></span></p>",
      "unique_key": "DT1289656",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289656,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Adenomyosis is characterized by a thickened junctional zone on MRI, often greater than 12 mm. The increased thickness of the junctional zone is a hallmark feature of adenomyosis.</strong></p>\r\n<p><strong>OPTION A: </strong>While uterine fibroids can be evaluated using MRI, they typically do not present with a junctional zone thickness greater than 12 mm. Fibroids are more likely to be identified as discrete masses within the uterus.</p>\r\n<p><strong>T1-weighted images</strong>: Fibroids generally have low to intermediate signal intensity.</p>\r\n<p><strong>T2-weighted images</strong>: Fibroids usually appear as well-defined areas of low signal intensity due to their fibrous content.</p>\r\n<p><strong>OPTION B:</strong> Endometrial carcinoma may present with thickening of the endometrium, but a junctional zone thickness greater than 12 mm is more characteristic of adenomyosis. MRI findings in endometrial carcinoma would more commonly focus on endometrial thickening and potential infiltration.</p>\r\n<p><strong>OPTION D: </strong>While chronic endometritis can cause changes in the endometrial lining, it does not typically result in a significantly thickened junctional zone.</p>\r\n<p><strong>KEY TAKEAWAY: </strong>A junctional zone thickness greater than 12 mm on MRI is highly indicative of adenomyosis, distinguishing it from other uterine conditions.</p>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrioma</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermoid cyst</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian cystadenoma</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Corpus luteal cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman presents with abdominal pain, and her pelvic ultrasound reveals a cystic ovarian mass. An MRI of the pelvis is performed, showing a characteristic \"dot-dash\" pattern within the cyst. What is the most likely diagnosis in this case?</span></p>",
      "unique_key": "DT1289657",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289657,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Dermoid cysts, or mature cystic teratomas, often show a characteristic \"dot-dash\" pattern on MRI, where the \"dots\" represent areas of high signal intensity (often fat) and the \"dashes\" represent areas of lower signal intensity (often calcifications)</strong>.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412077e96af09-bc80-47a6-aec7-010fce8aaa02.jpg\">\r\n<p><strong>OPTION A: </strong>Endometrioma typically appears as a cyst with low signal intensity on T2-weighted MRI and may show internal echogenicity due to blood or endometrial tissue, but it does not exhibit the \"dot-dash\" pattern.</p>\r\n<p><strong>OPTION C: </strong>Ovarian cystadenoma typically appears as a unilocular or multilocular cystic mass on MRI without the characteristic \"dot-dash\" pattern.</p>\r\n<p><strong>OPTION D: </strong>Corpus luteal cysts usually appear as cystic masses with a more homogeneous appearance on MRI. They can show peripheral enhancement and do not typically display the \"dot-dash\" pattern. They are often associated with the menstrual cycle and may resolve spontaneously.</p>\r\n<p>KEY TAKEAWAY: <strong>The \"dot-dash\" pattern observed on MRI is indicative of a dermoid cyst distinguishing it from other types of ovarian masses.</strong></p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Better differentiation of benign from malignant lesions</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Higher resolution of anatomical structures</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Ability to assess both metabolic activity and anatomical detail</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Lower radiation exposure compared to CT alone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">PET-CT is increasingly used in the management of gynecological cancers. Which out of the following is the most striking primary advantage of PET-CT over traditional imaging modalities? (Choose the most appropriate answer)</span></p>",
      "unique_key": "DT1289659",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289659,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>OPTION A: </strong>While PET-CT can provide useful information about the metabolic activity of lesions, <strong>it does not always differentiate benign from malignant lesions as accurately as other modalities.</strong> For instance, some benign conditions can also show increased metabolic activity, e.g. inflammatory abscess, chronic inflammatory granulomas etc.</p>\r\n<p><strong>OPTION B: </strong>While PET-CT does offer precise anatomical details, its primary advantage is not the resolution of anatomical structures, which is typically better assessed by CT alone or MRI. The key advantage of PET-CT lies in combining metabolic and anatomical information.</p>\r\n<p><strong>OPTION C: PET-CT uniquely combines the functional imaging of PET (which shows metabolic activity) with the anatomical imaging of CT. This dual capability allows for a comprehensive assessment of both the location and activity of tumors, which is crucial for staging and treatment planning.</strong></p>\r\n<p><strong>OPTION D: PET-CT generally involves a higher radiation dose compared to a standard CT scan</strong> because it combines both PET and CT imaging.</p>\r\n<p><strong>KEY TAKE AWAY: </strong>The primary advantage of PET-CT in managing gynecological cancers is its ability to provide both metabolic and anatomical information.</p>\r\n<p><strong><em><u>Principle of PET-CT</u></em></strong></p>\r\n<ul>\r\n<li><strong>Radioactive Tracer</strong>: PET-CT uses radioactive tracers, most commonly fluorodeoxyglucose (FDG), which is a glucose analog tagged with a radioactive isotope (fluorine-18).</li>\r\n<li><strong>Metabolic Activity</strong>: <strong>Tumor cells often have higher glucose metabolism than normal cells.</strong> FDG is taken up by cells that are actively metabolizing glucose. Malignant cells, due to their increased metabolic rate and rapid proliferation, tend to show higher FDG uptake.</li>\r\n<li><strong>Emission Detection</strong>: The PET scanner detects the positrons emitted by the radioactive tracer as it decays. These positrons collide with electrons in the body, producing gamma rays. The PET scanner detects these gamma rays to create images of metabolic activity.</li>\r\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Gas embolism</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Bowel perforation</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureteral injury</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a laparoscopic ovarian cystectomy, the surgeon encounters an unexpected decrease in the patient's blood pressure and an increase in heart rate. Additionally, the patient's oxygen saturation drops. The woman also reports sudden chest pain. Which of the following is the most likely complication?</span></p>",
      "unique_key": "DT1289662",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289662,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>A gas embolism occurs when <strong>CO<sub>2</sub></strong> or other gases enter the venous circulation, causing sudden cardiovascular and respiratory symptoms, including chest pain and decreased oxygen saturation.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120750d28c76-b62b-4aca-9e9b-60b3b6574e91.jpg\">\r\n<p><strong>OPTION A: </strong>Pneumothorax is less likely to cause sudden cardiovascular symptoms and oxygen saturation changes during laparoscopy.</p>\r\n<p><strong>OPTION C: </strong>Bowel perforation is typically associated with abdominal pain and peritoneal signs rather than acute cardiovascular changes.</p>\r\n<p><strong>OPTION D: </strong>Ureteral injury usually presents with signs of urinary tract damage, not acute cardiovascular symptoms.</p>\r\n<p>KEY TAKEAWAY: Gas embolism is a serious complication that requires immediate intervention, such as <strong>positioning the patient in the left lateral decubitus position I.e durant's position</strong> and providing supportive care.</p>\r\n<p><strong>Reference: </strong>www.reasearchgate.com</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Incorrect placement of the Veress needle in the subcutaneous tissue</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Malfunctioning of CO<sub>2</sub> insufflation device</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">The patient has a large ovarian cyst that is obstructing the needle</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">The abdominal wall has excessive adipose tissue</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 31-year-old woman is scheduled for a laparoscopic ovarian drilling. The surgeon decides to use the Veress needle technique for initial pneumoperitoneum creation. During the procedure, the surgeon encounters resistance upon insertion of the Veress needle and notes that the pressure on the insufflation device is not increasing as expected. What is the most likely cause of this issue?</span></p>",
      "unique_key": "DT1289664",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289664,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>If the Veress needle is not correctly placed in the peritoneal cavity, it may be in the subcutaneous tissue or preperitoneal space, causing resistance and failure to achieve the expected insufflation pressure.</p>\r\n<p><strong>OPTION B: </strong>While device malfunction could be a cause, it is less likely than improper needle placement. Malfunction would typically be evident in other ways, such as erratic pressure readings.</p>\r\n<p><strong>OPTION C: </strong>A large ovarian cyst would not typically obstruct the Veress needle unless there was an abnormal placement.If properly placed,<strong> the needle should still enter the peritoneal cavity.</strong></p>\r\n<p><strong>OPTION D: </strong>While excessive adipose tissue can make insertion more difficult, it should not prevent the increase in insufflation pressure if the needle is correctly placed.</p>\r\n<p><strong>KEY TAKEAWAY</strong>: <strong>Proper placement of the Veress needle is crucial for effective pneumoperitoneum. Issues with resistance and insufflation pressure often indicate incorrect needle placement, requiring adjustment or re-positioning to achieve the desired outcome.</strong></p>\r\n<p><strong>Reference</strong>: www.researchgate.com</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine perforation</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperglycemic crisis</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluid overload</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary embolism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman is undergoing hysteroscopic resection of a large endometrial polyp. During the procedure, the surgical team uses a saline solution for uterine distension. Midway through the procedure, the patient begins to exhibit signs of discomfort. The anesthesiologist reports a sudden decrease in blood pressure and a marked increase in heart rate. The patient also shows signs of swelling in the lower extremities and has a sudden drop in serum sodium levels. Which of the following is the most likely diagnosis based on these signs?</span></p>",
      "unique_key": "DT1289668",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289668,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The sudden decrease in blood pressure, increased heart rate, swelling in the lower extremities, and drop in serum sodium levels are indicative of fluid overload. This occurs when excess fluid absorption during the procedure leads to systemic effects.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120781c6f97f-d4a3-48fe-b361-095883d4562d.jpg\">\r\n<p><strong>KEY TAKEAWAY</strong>: <strong>Fluid overload is a serious complication of hysteroscopy, particularly when excessive amounts of distension fluid (glycine ,normal saline etc ) are absorbed, leading to systemic symptoms and electrolyte imbalances.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412075f46aad5-278c-429c-956e-f3dc9c998da7.jpg\">\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207b471d8bc-49f5-460a-b46a-9b8899e1990c.jpg\">",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovulation induction</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform hysteroscopic myomectomy</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Proceed with in vitro fertilization (IVF)</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait & watch for spontaneous resorption</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28 year-old woman with a history of primary infertility undergoes diagnostic hysteroscopy. The procedure reveals a large submucosal fibroid causing distortion of the uterine cavity. What is the most appropriate management for this finding?</span></p>",
      "unique_key": "DT1289672",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289672,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Submucosal fibroid causing <strong>distortion of the uterine cavity can affect fertility</strong> and should be resected to improve the chances of conception.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207746cfb3b-f09b-4452-aee5-d04f67595a0f.jpg\">\r\n<p><strong>OPTION A: </strong>Clomiphene is used for ovulation induction and does not address structural abnormalities.</p>\r\n<p><strong>OPTION C: </strong>While IVF may be considered later, addressing the structural abnormality with myomectomy is usually a first step.</p>\r\n<p><strong>OPTION D: </strong>Waiting without addressing the fibroid could prolong infertility issues.</p>\r\n<p><strong>KEY TAKEAWAY</strong>: <strong>Submucosal fibroids can distort the uterine cavity, interfere with implantation, and cause abnormal bleeding. Hysteroscopic myomectomy is indicated when fibroids are identified as a contributing factor to infertility.</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207173efbec-0307-4230-9a5a-57dfbdf83404.jpg\">",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Total Abdominal Hysterectomy (TAH) with Bilateral Salpingo-Oophorectomy (BSO)</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Radical Hysterectomy</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Vaginal Hysterectomy</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparoscopic Hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 64-year-old woman is diagnosed with Stage IIA cervical cancer. What type of hysterectomy is most appropriate for this patient?</span></p>",
      "unique_key": "DT1289674",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289674,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Radical Hysterectomy </strong>is suitable for Stage II cervical cancer, involving removal of the uterus, cervix, upper part of the vagina, and pelvic lymphadenectomy. This procedure aims to remove all possible cancerous tissues and is the standard approach for this stage of cervical cancer.</p>\r\n<p><strong>OPTION A:</strong> <strong>Total Abdominal Hysterectomy (TAH) with Bilateral Salpingo-Oophorectomy (BSO) </strong>may be used for earlier stages but is not sufficient for Stage II malignancy without additional procedures.</p>\r\n<p><strong>OPTION C: </strong>Vaginal hysterectomy is not typically used for cancer treatment due to limitations in staging and removal.</p>\r\n<p><strong>OPTION D: </strong>Laparoscopic surgery is less commonly used for malignancies of this stage without additional procedures.</p>\r\n<p><strong>KEY TAKEAWAY</strong>: <strong>Radical hysterectomy</strong> is the preferred method for Stage IIA cervical cancer as it ensures comprehensive removal of cancerous tissues and allows for accurate staging.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207ef7bb3b2-fbd0-42cf-8bd7-425df56c2947.jpg\">",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine Perforation</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine Rupture</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical Laceration</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Couvelaire uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38 year-old woman with a history of abnormal bleeding undergoes a D&C. During the procedure, the surgeon notes that the uterine wall feels unusually soft, and there is a sudden loss of resistance with the curette. The patient develops tachycardia and hypotension post-operatively. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1289676",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289676,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Uterine Perforation </strong>is suggested by the sudden loss of resistance, tachycardia, and hypotension, indicating potential internal bleeding.</p>\r\n<p><strong>OPTION B: </strong>Uterine rupture is a more severe and rare complication, often associated with previous uterine surgery or trauma. It typically presents with more severe symptoms and a dramatic clinical picture, including significant abdominal pain, and may not be directly related to a D&amp;C procedure.</p>\r\n<p><strong>OPTION C: </strong>Cervical lacerations can occur during procedures but are less likely to cause the combination of symptoms described (unusual softness of the uterine wall, sudden loss of resistance, tachycardia, and hypotension) compared to uterine perforation.</p>\r\n<p><strong>OPTION D: </strong>Couvelaire Uterus is associated with severe placental abruption and results in a bruised appearance of the uterus. It is unrelated to a D&amp;C procedure and would not typically present in the described context.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<p><strong>Initial Management of Uterine Perforation: </strong></p>\r\n<ul>\r\n<li>Administer intravenous fluids to manage shock.</li>\r\n<li>Monitor vital signs closely.</li>\r\n<li>Perform a pelvic ultrasound to assess for free fluid or bleeding.</li>\r\n<li>Start broad-spectrum antibiotics to prevent infection.</li>\r\n<li>Laparoscopy/Laparotomy if required.</li>\r\n</ul>",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">At the level of the infundibulopelvic ligament</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Near the uterine artery</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">At the level of the cervix</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">At the ureterovesical junction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most common site of ureteral injury during a pelvic surgery:</span></p>",
      "unique_key": "DT1289679",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289679,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Near the uterine artery</strong>: The ureter is most commonly injured near the uterine artery because of its close proximity and frequent manipulation during pelvic surgeries, particularly those involving the uterus and cervix.</p>\r\n<p><strong>OPTION A: At the level of the infundibulopelvic ligament</strong>: Although injury can occur here, it is less common compared to the area near the uterine artery. The infundibulopelvic ligament is more related to ovarian surgery.</p>\r\n<p><strong>OPTION C: At the level of the cervix</strong> ureteral injury can occur but its not very frequent. Mc common site is near the uterine artery.</p>\r\n<p><strong>OPTION D: At the ureterovesical junction</strong>: Injuries at the ureterovesical junction are more common in urological procedures rather than gynecological surgeries. This junction is less frequently involved in gynecological procedures compared to the area near the uterine artery.</p>\r\n<p>KEY TAKEAWAY: The area near the uterine artery is a critical site for potential ureteral injury during gynecological surgeries due to anatomical proximity and surgical manipulation.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120753aced57-b94f-4a5c-9739-1aa77bb4c74e.jpg\">\r\n<p>The phrase <strong><em>\"water under the bridge\"</em></strong> is often used in surgical contexts to describe the anatomical relationship between structures. For uterine artery and ureter injury, this phrase helps remember the relationship and common site of injury.</p>\r\n<p>Here's how it applies to uterine artery and ureter injuries:</p>\r\n<p><strong>\"Water Under the Bridge\" Mnemonic</strong></p>\r\n<ul>\r\n<li><strong>Water</strong>: Represents the <strong>Ureter</strong>.</li>\r\n<li><strong>Under</strong>: Represents the <strong>Uterine Artery</strong> as the \"bridge\" over the ureter.</li>\r\n<li><strong>The Bridge</strong>: Indicates that the uterine artery crosses over the ureter.</li>\r\n</ul>\r\n<p>In pelvic surgery, <strong>particularly during hysterectomy or other gynecological procedures, the ureter runs underneath the uterine artery</strong>. The uterine artery crosses over the ureter, making it a common site for injury during surgical manipulation around the uterine artery.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Total abdominal hysterectomy with bilateral salpingo-oophorectomy</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian cystectomy</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral oophorectomy alone</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Exploratory laparotomy and tumor debulking</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most appropriate surgical approach for a patient with Stage I ovarian cancer?</span></p>",
      "unique_key": "DT1289681",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289681,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Exploratory laparotomy and tumor debulking</strong>: Appropriate for assessing the extent of disease and removing as much tumor as possible (complete cytoreduction) in Stage I ovarian cancer.</p>\r\n<p>RISK FACTOR FOR OVARIAN CANCER</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207720837b0-4db8-46fc-9472-0554a122d632.jpg\">\r\n<p>Protective factors</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207cae3473d-7cda-4871-82c8-ca6a13544339.jpg\">\r\n<p><strong>OPTION A: Total abdominal hysterectomy with bilateral salpingo-oophorectomy (TAH-BSO)</strong> may be part of the treatment but exploratory laparotomy and tumor debulking are more specific to managing ovarian cancer.</p>\r\n<p><strong>OPTION B: Ovarian cystectomy</strong> is not sufficient for Stage I ovarian cancer, which often requires more extensive surgical intervention.</p>\r\n<p><strong>OPTION C: Bilateral oophorectomy alone</strong> is an incomplete treatment for Stage I ovarian cancer, as it does not address potential peritoneal spread or tumor debulking.</p>\r\n<p><strong>KEY TAKEAWAY:</strong> Exploratory laparotomy is a critical procedure for managing ovarian cancer, providing crucial information for staging and enabling effective treatment through tumor debulking.</p>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Vesicovaginal Fistula</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectovaginal Fistula</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureteral Injury</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Postoperative peritonitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old woman undergoes vaginal hysterectomy for symptomatic uterine fibroids. Postoperatively, she develops abdominal pain, fever, and signs of peritoneal irritation. During the follow-up visit, she reports urinary incontinence and difficulty voiding. What is the most likely complication in this case?</span></p>",
      "unique_key": "DT1289683",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289683,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Vesicovaginal Fistula</strong> - This is a <strong>common complication of vaginal hysterectomy involving an abnormal connection between the bladder and the vagina, which can cause urinary incontinence and difficulty voiding.</strong> The presence of severe abdominal pain, fever, and peritoneal irritation suggests an infection or complication that might have led to fistula formation.</p>\r\n<p><strong>Option B: Rectovaginal Fistula </strong>- This involves an abnormal connection between the rectum and the vagina, leading to fecal incontinence rather than urinary symptoms. The presented symptoms are more indicative of a vesicovaginal fistula.</p>\r\n<p><strong>Option C: Ureteral Injury</strong> - This would typically present with flank pain, fever, and possibly anuria or oliguria, but not usually with urinary incontinence and difficulty voiding alone.</p>\r\n<p><strong>Option D: Postoperative peritonitis</strong> - This typically presents with generalized abdominal pain, fever, and signs of peritoneal irritation. While this condition can be associated with fever and abdominal pain, it would not directly explain the urinary incontinence and difficulty voiding observed in this patient.</p>\r\n<p><strong>KEY TAKEAWAY</strong>: <strong>The combination of urinary incontinence, difficulty voiding, abdominal pain, and fever strongly suggests a vesicovaginal fistula as the most likely complication following vaginal hysterectomy</strong>.</p>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Cisplatin & 5-fluorouracil</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Paclitaxel and carboplatin</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin and cyclophosphamide</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Etoposide & Gemcitabine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62 year old postmenopausal woman is suffering from Stage III Ovarian cancer. Which chemotherapy regimen is commonly used as first-line treatment for advanced ovarian cancer?</span></p>",
      "unique_key": "DT1289684",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289684,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Chemotherapy in ovarian cancer</em></strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207a8cd5e4c-0228-47e5-b60b-9623f1482afe.jpg\">\r\n<p><strong>OPTION A: Cisplatin &amp; 5-fluorouracil</strong> - While cisplatin is used in ovarian cancer treatment, 5-fluorouracil is not typically used in the treatment of ovarian cancer. This combination is more often used for other types of cancers, such as <strong>gastrointestinal cancers</strong>.</p>\r\n<p><strong>OPTION B: Paclitaxel and carboplatin</strong> -<strong>This is the standard first-line chemotherapy regimen for advanced ovarian cancer. </strong>Paclitaxel (a taxane) and carboplatin (a platinum-based drug) work synergistically to target and kill cancer cells, making this combination highly effective for treating advanced stages of ovarian cancer.</p>\r\n<p><strong>OPTION C: Doxorubicin and cyclophosphamide</strong> - This combination is more commonly used for <strong>breast cancer</strong> and some other malignancies, but it is not the standard treatment for ovarian cancer.</p>\r\n<p><strong>OPTION D: Etoposide &amp; Gemcitabine</strong>: While both are used in cancer treatment, they are not typically used as the first-line treatment for ovarian cancer. Etoposide is more commonly used in testicular cancer and small cell lung cancer, and gemcitabine is used for other types of cancer.</p>\r\n<p><strong>KEY TAKEAWAY</strong>: Paclitaxel and carboplatin remains the first-line treatment for advanced ovarian cancer due to its proven efficacy in clinical trials.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver function tests</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal function tests</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete blood count</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">High sensitivity CRP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman is being prepared for methotrexate chemotherapy as part of her treatment for choriocarcinoma. Before initiating MTx chemotherapy, which of the following tests is NOT required?</span></p>",
      "unique_key": "DT1289687",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>OPTION A: </strong>Methotrexate can cause <strong>hepatotoxicity</strong>, so assessing liver function is important. <br /> <strong>OPTION B: </strong>Methotrexate is excreted through the kidneys, and assessing renal function is crucial to avoid nephrotoxicity and adjust dosages if needed.</p>\r\n<p><strong>OPTION C: </strong>Complete blood count: Methotrexate can cause myelosuppression, so baseline CBC is essential to monitor for potential adverse effects like anemia, leukopenia, or thrombocytopenia.</p>\r\n<p><strong>OPTION D: </strong>High sensitivity CRP is not essential before starting methotrexate chemotherapy. It is more useful for detecting and monitoring inflammatory conditions rather than directly related to chemotherapy management.</p>\r\n<p><strong>KEY TAKEAWAY: </strong>Liver function tests, renal function tests, and complete blood count are required before starting methotrexate therapy.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412073831b26f-03a3-46ec-992f-c841d2200ce7.jpg\">",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Etoposide</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Olaparib</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Bevacizumab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 46-year-old nulliparous woman with advanced ovarian cancer is diagnosed to have a BRCA1 mutation. Her disease has progressed despite first-line chemotherapy. Which of the following treatments is most appropriate in this case?</span></p>",
      "unique_key": "DT1289688",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Olaparib </strong>is a PARP (Poly (ADP-ribose) polymerase) inhibitor used for treating ovarian cancer, particularly effective in patients with BRCA1 or BRCA2 mutations. It works by exploiting the defective DNA repair mechanisms in BRCA-mutant tumors. <strong>In cancers with defective DNA repair mechanisms (like BRCA1 or BRCA2 mutations), PARP inhibition leads to the accumulation of DNA damage, causing cancer cell death.</strong> This is because the cells are unable to repair both single- and double-strand breaks.</p>\r\n<p><strong>OPTION A: Etoposide</strong> is a chemotherapeutic agent that inhibits DNA topoisomerase II, which is crucial for DNA replication and repair. toposide is not specifically targeted to BRCA mutations but may be used when other treatment options are exhausted or in combination regimens.</p>\r\n<p><strong>OPTION B: Doxorubicin</strong> is an anthracycline antibiotic that inhibits DNA topoisomerase II, intercalates into DNA, and generates free radicals. This results in DNA damage and cell death. Doxorubicin is not a standard treatment for BRCA1-mutated ovarian cancer. It is generally used for other types of cancers or in specific salvage regimens, rather than as a primary treatment for BRCA1-related ovarian cancer.</p>\r\n<p><strong>OPTION D: Bevacizumab</strong> is a monoclonal antibody targeting vascular endothelial growth factor (VEGF) and is used to treat ovarian cancer in combination with chemotherapy. While it can be used in ovarian cancer, it is not specific to BRCA1 mutations and does not address the underlying genetic defect as directly as PARP inhibitors do. It is generally used for patients with platinum-resistant or platinum-sensitive recurrent ovarian cancer. <strong>Its use may be considered in cases with significant ascites if it is associated with disease progression and angiogenesis.</strong></p>\r\n<p><strong>KEY TAKEAWAY: </strong>PARP inhibitors are particularly effective in treating ovarian cancer associated with BRCA1 or BRCA2 mutations due to their ability to target cancer cells with defective DNA repair mechanisms.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian failure</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Cognitive dysfunction</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute cystitis</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral neuropathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56 year old woman is diagnosed with Stage III cervical cancer. She is undergoing concurrent chemoradiation. Which of the following is a common acute side effect of pelvic radiation therapy in patients with cervical cancer?</span></p>",
      "unique_key": "DT1289690",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289690,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Acute cystitis is a common acute side effect of pelvic radiation therapy. </strong>It involves inflammation of the bladder, leading to symptoms like dysuria (painful urination), increased urinary frequency, and sometimes hematuria (blood in urine). This occurs due to the direct effect of radiation on the bladder tissues</p>\n<p><strong>OPTION A: </strong>Ovarian failure is more commonly a long-term side effect of pelvic radiation therapy, especially when the ovaries are directly exposed. While it can occur, it is not typically considered an acute side effect. Acute side effects are those that appear during or shortly after the course of treatment.</p>\n<p><strong>OPTION B:</strong> Cognitive dysfunction is not a common side effect of pelvic radiation therapy. It is more associated with radiation to the brain or central nervous system. Pelvic radiation primarily affects the reproductive and surrounding organs, not cognitive functions.</p>\n<p><strong>OPTION D: </strong>Peripheral neuropathy is generally associated with certain chemotherapy agents e.g. Taxanes, Platinum agents, Vinca alkaloids etc., rather than radiation therapy. While radiation can cause nerve damage, it is not commonly categorized as an acute side effect of pelvic radiation therapy.</p>\n<p>KEY TAKEAWAY:</p>\n<p><strong><em>Prevention/Treatment of Acute Cystitis following radiotherapy:</em></strong></p>\n<ul>\n<li>Hydration to flush out irritants.</li>\n<li>Cranberry supplements (limited evidence).</li>\n<li>Medications: Anti-inflammatory agents, antispasmodics, and pain relievers.</li>\n<li>Bladder instillations with agents like hyaluronic acid to protect the bladder lining.</li>\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Point A is located 2 cm lateral to the central canal of the uterus and 2 cm superior to the external os, representing the dose to the paracervical tissues</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Point B is located 3 cm lateral to the midline at the level of the external os, representing the dose to the obturator lymph nodes</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Point A is located 2 cm lateral and 2 cm inferior to the cervical os, representing the dose to the vaginal tissues</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Point B is located 5 cm lateral to the midline and 5 cm superior to the external os, representing the dose to the uterine fundus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old woman with Stage IIB cervical cancer is receiving brachytherapy as part of her treatment plan. During the planning of her radiotherapy, the oncologist discusses the importance of delivering an optimal dose to specific reference points known as Point A and Point B. Which of the following statements best describes these points?</span></p>",
      "unique_key": "DT1289692",
      "question_audio": null,
      "question_video": null,
      "map_id": 1289692,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241207aa6e390f-3e38-4854-8a0d-ab4fcd8e9599.jpg\">\r\n<p><strong>Point A</strong> is the reference point used in brachytherapy for cervical cancer, <strong>located 2 cm lateral to the central canal and 2 cm superior to the external os</strong>. It represents the dose to the <strong>paracervical tissues</strong>, which is critical for treating the primary tumor and the surrounding parametrial tissue.</p>\r\n<p><strong>Point B</strong> is actually located <strong>5 cm lateral to the midline</strong> at the level of the <strong>external os</strong>, representing the dose to the <strong>pelvic sidewall</strong>, including the obturator lymph nodes.</p>\r\n<p><strong>KEY TAKEAWAY:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024120788c68ef8-0e85-4634-ba1d-9f353fabe490a.jpg\">",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}